Company
Dogwood Therapeutics, Inc. (DWTX)
Standardized SEC financial data for Dogwood Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001818844 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-45.7%
Free cash flow
-$15.6M
Current ratio
2.76×
EPS (diluted)
$-7.13
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $194K | $10.8M | $8.1M | $1.7M | $3.5M | $21.9M |
| SG&A expense |
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2024 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.0M | $3.3M | — | — | $14.8M | $6.5M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$3.9M | -$15.7M | -$11.5M | -$4.9M | -$8.8M | -$15.6M |
| Investing cash flow |
Get DWTX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/DWTX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/DWTX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"